Home > ResourceBlog > Article

« All ResourceBlog Articles

 

Bookmark and Share   Feed

Saturday, 17th July 2010

Wolfram|Alpha Adds New Content: Medical Drug Treatments

The new datasets just keep coming.

From a Blog Post:

A new medical diagnosis or drug treatment can often leave us with more questions than answers. A few weeks ago we introduced a disease dataset within Wolfram|Alpha that can be helpful for those wondering how their condition and treatment plans compare to those of other patients. Most notably, this dataset includes the fraction of patients within the United States that have been diagnosed with a medical condition in a given year. For each condition, Wolfram|Alpha has various levels of information, including commonly reported symptoms, co-occurring diseases, and lab tests used for diagnosis. Beyond this, Wolfram|Alpha also has carefully curated data on drug treatments.

For example:

+ drugs used to treat anemia
+ drug treatments diabetes
+ pharmaceuticals used to treat the flu

The data displayed from these inputs gives classes of drugs prescribed or administered to patients during health care provider visits. Wolfram|Alpha ranks the drug classes by the number of patients to whom they were administered.

[Snip]

Wolfram|Alpha can also can also provide generic options for prescription drug treatments. For example, by searching “drug treatments for depression” and pressing “Show drugs” and then selecting “Generic drugs” from the available options, we can see that though Lexapro, Zoloft, and Celexa are the top three most prescribed brand-name selective serotonin reuptake inhibitor (SSRI) drugs, switching to the generic drug view indicates that escitalopram, sertaline, and fluoxetine are the top-ranked generic drugs. This is interesting because if we switch back to the brand-name list, escitalopram (generic for Lexapro) and sertraline (generic for Zoloft) remain at the top two positions, but citalopram (generic for Celexa) drops off the top three and is replaced by fluoxetine (generic for Prozac). Further, by pressing the “More drugs” option at the top and switching between the generic and brand-name views, we can see that the percentage of females prescribed citalopram is 6.9% versus 4.7% for Celexa. This indicates that, although they are the same basic drug, another more obscure brand name version of citalopram is prescribed far less than Celexa.

Here are a few more examples:

+ Strep Throat

+ Smoking in Lung Cancer Patients (co-occurrence) or

+ Average Age of Tonsillitis Patients

+ Average Height of 40 Year Old Male

+ Tinnitus

Many more examples and screenshots in the remainder of the Wolfram|Alpha blog post.

Source: Wolfram|Alpha Blog

Views: 2199




« All ResourceBlog Articles

 

FreePint

FreePint supports the value of information in the enterprise. Read more »


FeedLatest FreePint Content:


  • Click to view the article Changing Compliance Culture in the Financial Sector
    Thursday, 24th July 2014

    In a speech at the annual Thomson Reuters Compliance & Risk Summit Tracey McDermott of the UK Financial Conduct Authority spoke about the change in focus of the regulator towards corporate culture and the enforcement of personal liability by management. The shift from rules-based regulation to the harder to measure compliance culture may require information managers to review the compliance information in their organisation and who receives it.

  • Click to view the article Product Review of Reg-Track (Sources - Content & Coverage)
    Thursday, 24th July 2014

    In the second part of his review, Chris Porter looks at content coverage in Reg-Track, a regulatory tracking service aimed at compliance professionals focused on the financial services industry. With a focus on the largest financial markets, such as those within North America, the European Union and Asia-Pacific, Reg-Track is also expanding its coverage to additional regulators.

  • Click to view the article Are We Becoming Too Scared of Security to Benefit from Big Data?
    Thursday, 24th July 2014

    Information assets are in the hands of the right people to safeguard them but the wrong people to manage their exploitation concludes an influential new study. As reports continue to emerge of apparent corporate paralysis in the face of cyber security threats, Tim Buckley Owen wonders whether the emphasis hasn't swung too far in that direction, and sees opportunities for information professionals in helping to strike a balance between security in the cloud and effective data analysis for competitive advantage.

  • ... more ...

All FreePint Content »
FreePint Topics »


A FreePint Subscription delivers articles and reports that support your organisation's information practice, content and strategy.

Find out more and order a FreePint Subscription by visiting the
completing our online form: Subscription Order page.


FreePint Testimonials

"It was really useful to get so much input from customers and hear their perspective - I have come into the office this morning full of things ..."

Read more testimonials and supply yours »






 

 
 
 

Register

Register to receive the free ResourceShelf Newsletter, featuring highlighted posts.

Find out more »

Article Categories

All Article Categories »

Archive

All Archives »